NovaBay Pharma (NBY) Reports Q1 Loss of $0.28/Share
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Basic and diluted (in Dollars per share): -0.34
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Basic and diluted (in Dollars per share): -0.34
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q1 EPS of ($0.28), versus ($0.13) reported last year. Revenue for the quarter came in at $1.5 million, versus $2.9 million reported last year.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- InspireMD (NSPR) Tops Q2 EPS by 1c
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
